{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:31:55Z","timestamp":1781659915780,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":5169,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.fertnstert.2007.04.010","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T08:44:33Z","timestamp":1202287473000},"page":"860-867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Follicular fluid anti-M\u00fcllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles"],"prefix":"10.1016","volume":"89","author":[{"given":"Jung Ryeol","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Mie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Chul","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yup","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Suk","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Gu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Yong","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2007.04.010_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antimullerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","article-title":"Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study","volume":"83","author":"van Rooij","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib3","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/humrep\/deg043","article-title":"Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","article-title":"Serum antimullerian hormone\/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol","volume":"82","author":"Hazout","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib7","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","article-title":"Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib9","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0303-7207(98)00186-5","article-title":"The role of anti-Mullerian hormone in gonadal development","volume":"145","author":"Josso","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib11","first-page":"711","article-title":"Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid mullerian-inhibiting substance and androgen content","volume":"76","author":"Seifer","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2004.02.011","article-title":"Inhibins and adult ovarian function","volume":"225","author":"Laven","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib13","first-page":"105","article-title":"Female reproductive aging is marked by decreased secretion of dimeric inhibin","volume":"84","author":"Welt","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0015-0282(97)81865-1","article-title":"Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome","volume":"67","author":"Seifer","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0015-0282(99)00193-4","article-title":"Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone","volume":"72","author":"Seifer","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction: a Cochrane review","volume":"17","author":"Al-Inany","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001750.pub2","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","volume":"3","author":"Al-Inany","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1472-6483(10)61749-X","article-title":"Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment","volume":"7","author":"Roulier","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","article-title":"Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)","volume":"73","author":"Olivennes","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group","volume":"15","author":"Albano","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/humrep\/14.4.885","article-title":"Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?","volume":"14","author":"Lin","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib22","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/humrep\/17.7.1724","article-title":"The concentration of inhibin B in follicular fluid: relation to oocyte maturation and embryo development","volume":"17","author":"Chang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2004.01.034","article-title":"Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome?","volume":"115","author":"Ocal","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.fertnstert.2005.01.115","article-title":"Per-follicle measurements indicate that anti-mullerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status","volume":"84","author":"Fanchin","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-291X(92)91556-6","article-title":"Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor","volume":"189","author":"Kakar","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib27","first-page":"1458","article-title":"High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines","volume":"77","author":"Emons","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib28","first-page":"3215","article-title":"Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro","volume":"81","author":"Chegini","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2007.04.010_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/humrep\/14.suppl_1.194","article-title":"Pituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analogues","volume":"14","author":"Ortmann","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/molehr\/5.3.234","article-title":"GnRH mRNA and protein expression in human preimplantation embryos","volume":"5","author":"Casan","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/humrep\/12.4.769","article-title":"Specific gonadotrophin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human pre-ovulatory follicles","volume":"12","author":"Brus","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib32","first-page":"430","article-title":"Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells","volume":"80","author":"Minaretzis","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib33","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1210\/endo.141.5.7447","article-title":"Regulation of gonadotropin-releasing hormone and its receptor gene expression by 17beta-estradiol in cultured human granulosa-luteal cells","volume":"141","author":"Nathwani","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib34","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/humrep\/15.6.1211","article-title":"Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists","volume":"15","author":"Hernandez","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/humrep\/16.4.608","article-title":"Embryo implantation and GnRH antagonists: ovarian actions of GnRH antagonists","volume":"16","author":"Ortmann","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib36","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/eje.0.1440677","article-title":"Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells","volume":"144","author":"Weiss","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/eje.0.1490031","article-title":"Actions of GnRH antagonists on IGF-II, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells","volume":"149","author":"Weiss","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib38","doi-asserted-by":"crossref","first-page":"RC5","DOI":"10.1007\/BF03344118","article-title":"IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol","volume":"29","author":"Asimakopoulos","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib39","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/humrep\/del091","article-title":"Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients","volume":"21","author":"Choi","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib40","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fertnstert.2006.01.046","article-title":"Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures","volume":"86","author":"Asimakopoulos","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib41","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.fertnstert.2004.11.027","article-title":"Vascular endothelial growth factor and inhibin A in follicular fluid of infertile patients who underwent in vitro fertilization with a gonadotropin-releasing hormone antagonist","volume":"83","author":"Cunha-Filho","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib42","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/humrep\/del207","article-title":"Cytokine and hormonal profile in blood serum and follicular fluids during ovarian stimulation with the multidose antagonist or the long agonist protocol","volume":"21","author":"Asimakopoulos","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humrep\/dei270","article-title":"Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology","volume":"21","author":"Silberstein","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib45","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/del127","article-title":"Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles","volume":"21","author":"Ebner","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib46","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/humrep\/14.10.2525","article-title":"Dimeric inhibins and activin A in human follicular fluid and oocyte-cumulus culture medium","volume":"14","author":"Lau","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.04.010_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.8755-8920.2000.430201.x","article-title":"Inhibin A, inhibin B and activin A in follicular fluid of infertile women with tubal damage, unexplained infertility and endometriosis","volume":"43","author":"Akande","year":"2000","journal-title":"Am J Reprod Immunol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207009661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207009661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:23:27Z","timestamp":1758007407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028207009661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0015028207009661"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.04.010","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follicular fluid anti-M\u00fcllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}